Related Experiment Video
Updated: Oct 11, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ)
Oksana Degtjarik1, Dmitrij Golovenko1,2, Yael Diskin-Posner3
1Department of Chemical and Structural Biology, Weizmann Institute of Science, 76100, Rehovot, Israel.
Abstract:
In response to genotoxic stress, the tumor suppressor p53 acts as a transcription factor by regulating the expression of genes critical for cancer prevention. Mutations in the gene encoding p53 are associated with cancer development. PRIMA-1 and eprenetapopt (APR-246/PRIMA-1MET) are small molecules that are converted into the biologically active compound, methylene quinuclidinone (MQ), shown to reactivate mutant p53 by binding covalently to cysteine residues. Here, we investigate the structural basis of mutant p53 reactivation by MQ based on a series of high-resolution crystal structures of cancer-related and wild-type p53 core domains bound to MQ in their free state and in complexes with their DNA response elements. Our data demonstrate that MQ binds to several cysteine residues located at the surface of the core domain. The structures reveal a large diversity in MQ interaction modes that stabilize p53 and its complexes with DNA, leading to a common global effect that is pertinent to the restoration of non-functional p53 proteins.
Insights
The small molecule methylene quinuclidinone (MQ) reactivates mutant p53 by binding to cysteine residues. Structural studies reveal diverse MQ binding modes that stabilize p53 and restore its function in cancer prevention.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- The tumor suppressor p53 is crucial for cancer prevention, regulating genes in response to genotoxic stress.
- Mutations in the p53 gene are linked to cancer development.
- Small molecules like PRIMA-1 and eprenetapopt are converted to methylene quinuclidinone (MQ), which reactivates mutant p53.
Purpose of the Study:
- To elucidate the structural basis of mutant p53 reactivation by MQ.
- To understand how MQ interacts with p53 core domains and DNA response elements.
Main Methods:
- High-resolution crystal structures of p53 core domains (wild-type and cancer-related mutants) were determined.
- Structures were analyzed in the presence of MQ, both in free state and complexed with DNA response elements.
Main Results:
- MQ binds to several surface cysteine residues on the p53 core domain.
- Diverse MQ interaction modes were observed, stabilizing p53 and its DNA complexes.
- These interactions lead to a common global effect restoring non-functional p53 proteins.
Conclusions:
- MQ's covalent binding to cysteine residues underlies mutant p53 reactivation.
- Structural insights reveal how MQ stabilizes p53 and restores its tumor suppressor function.
- This work provides a foundation for developing p53-targeting cancer therapies.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Spontaneous and Induced Mutations
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway

